Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEROTOX: Botulinum Toxin for Degenerative Rotator Cuff Disease
NCT05327972Phase 2Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2023
- Primary completion
- Feb 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in rotator cuff disease, sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2023; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
rotator cuff disease
Beyond the preview
Go deeper on NCT05327972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327972.